Condition

Renal Cancer (2)

Bladder Cancer (1)

Colorectal Cancer (1)

Head and Neck Cancer (1)

Melanoma (1)

Non-Small Cell Lung Cancer (1)

Other Solid Cancers (1)

Triple Negative Breast Cancer (1)

Overall Status

Active, not recruiting (2)

Phase

phase 1 (1)

Sponsor

Genentech, Inc. (1)

Memorial Sloan Kettering Cancer Center (1)

Intervention

(eortc qlq-c30) questionnaire (1)

atezolizumab (1)

autogene cevumeran (1)

euroqol eq-5d 7-item questionnaire (1)

Study Documents

Intervention Type

behavioral (1)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational [Patient Registry] (1)

Renal Cancer

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting

Melanoma
+7 more

Autogene cevumeran
Atezolizumab

Scottsdale, Arizona
+36 more

Dec 22, 2022

Renal Cancer Trial in United States ((EORTC QLQ-C30) questionnaire, EuroQol EQ-5D 7-item questionnaire)

Active, not recruiting

Renal Cancer

(EORTC QLQ-C30) questionnaire
EuroQol EQ-5D 7-item questionnaire

Los Angeles, California
+5 more

Feb 23, 2022